On this page you will find our recommendations sorted by BNF chapter.

Appraisal Reports are available to stakeholders on request.

Where a decision is >24 months old; these are highlighted in red. If you are a clinician working within the NTAG region and would like to prioritise an old decision for re-review please contact the professional secretary on nuth.nyrdtc.rxsupp@nhs.net

Title Documents Decision Date
Left atrial appendage occlusion devices for stroke prevention in patients with non-valvular atrial fibrillation (NETAG) Recommendation Recommended for patients with a proven bleeding risk which contraindicates anticoagulation therapy 10/07/2012
Stand-alone minimally invasive bipolar radiofrequency ablation for Atrial Fibrillation (NETAG) Recommendation Recommended for atrial fibrillation where catheter ablation is not suitable due to clinical, technical or anatomical reasons 12/07/2011


North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) NENC regional SGLT2 top tips v1.2 - NTAG approved March 2023 - update June 2023 Approved by NTAG 21/03/2023


NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF NENC Decision Aid incl Table to support decison of DOAC - approved June 2022 (extended to June 2024) Approved by NTAG 20/06/2023


Northern England Evaluation and Lipid Intensification guideline NEELI edit v2022.2-FINAL-NTAG Approved by NTAG 06/09/2022


NENC Shared Care Protocol Dronedarone for patients in adult services NENC Shared Care Protocol - Dronedarone - June 2023 Approved by NENC Medicines Subcommittee 20/06/2023